Clinical Trial Update: SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated radiotherapy with or without the chemotherapy combination of doxorubicin and vinblastine in early-stage Hodgkin lymphoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 3 | Status: COMPLETED